Spending on Pharmaceuticals in Italy: Macro Constraints with Local Autonomy

Vittorio Mapelli, Carlo Lucioni
2003 Value in Health  
Italy has a national health service (SSN) that is moving toward decentralization and empowerment of local health enterprises (LHEs)-the arms of the regions for delivering health services. Drug policy and spending decisions are both influenced by central government and local authorities. At the "macro" level, the government holds the power to decide the amount of drug expenditure, currently at 13% of total SSN expenditure; the pricing policy, price negotiation, reference price, and price cuts;
more » ... iteria for reimbursement, inclusion in the positive list, and restrictive notes; and the copayments and exemptions. So far, the government concern has been predominantly on cost containment, and its approach in selecting drugs for reimbursement has been cost minimization. Italy has no centralized office for health technology assessment and this hinders the search for an efficient use of drugs. At the "micro" level, however, the LHEs are showing
doi:10.1046/j.1524-4733.6.s1.4.x pmid:12846924 fatcat:bfeflrmjsjcddkneg5ynw5rxlu